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Background: Despite the increasing prevalence of pre-diabetes worldwide, there is insufficient literature on the
impact of gestational pre-diabetes on offspring outcomes. The objective of this systematic review is to determine
the risk of developing adverse outcomes for the offspring in women with pre-diabetes compared to women with
normal glucose levels and women with gestational diabetes mellitus.
Methods/design: A systematic search of the published literature will be conducted for experimental and observational
studies that report outcomes in the offspring of mothers with pre-diabetes during pregnancy. Databases including
EMBASE, PsycINFO, and PubMed will be searched from 1979 (the year when the terms impaired glucose tolerance and
pre-diabetes were coined) to December 2014. Screening of identified articles and data extraction will be conducted in
duplicate and independently. Methodological quality of the included studies will be assessed using the Newcastle-
Ottawa scale. Discrepancies will be resolved by consensus or by consulting a third author. Meta-analyses will be
performed, and findings will be reported according to the preferred reporting items for systematic reviews and
meta-analyses (PRISMA) and the meta-analysis of observational studies in epidemiology (MOOSE) guidelines.
Discussion: Determining the effect of pre-diabetes on offspring outcome will be important for clinicians providing care
to pregnant women and their offspring. This review will also identify any gaps in the current literature on this topic
and provide direction for future research in this area of study.
Systematic review registration: PROSPERO CRD42015015536
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The prevalence of pre-diabetes (a condition in which
blood sugar levels are higher than normal but are below
levels found in clinical diabetes) is rising worldwide. It is
estimated that about 470 million people will be diag-
nosed with pre-diabetes globally by the year 2030 [1].
Pre-diabetes includes impaired fasting glucose, impaired
glucose tolerance, and hemoglobin A1c of 6% to 6.4%
[2]. Currently, the crude prevalence of pre-diabetes in
the United States is roughly 30% among individuals
greater than 20 years old [3]. The Canadian Diabetes
Association (CDA) estimates that 5.7 million out of the* Correspondence: kmorrison@mcmaster.ca
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unless otherwise stated.35 million Canadians have pre-diabetes [4]. Adults
with pre-diabetes have an increased risk of developing
Type 2 diabetes mellitus (T2DM) [5] and cardiovascu-
lar disease [6].
During pregnancy, women can develop a dysglycemic
state known as gestational diabetes mellitus (GDM).
Although most women with GDM have normal blood
sugars after delivery, the risk of developing subsequent
T2DM is higher [7]. The diagnostic criteria for GDM
vary internationally but generally involve a two-step
process: an initial screening challenge with glucose
followed by a standardized 75 (or 100) g oral glucose
tolerance test (OGTT) if the screen is abnormal. More
details on the classification of GDM are included in the
methods. This dysglycemic state during pregnancy has
been found to influence fetal development and has both. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[8]. GDM is independently associated with macrosomia,
shoulder dystocia, pre-term delivery, caesarian deliver-
ies, and perinatal mortality [9]. Long-term outcomes of
GDM in the offspring include obesity and abnormal glu-
cose metabolism during childhood, adolescence, and adult-
hood [10,11]. Recent results from the hyperglycemia and
adverse pregnancy outcome (HAPO) study have suggested
that even milder levels of hyperglycemia can have adverse
effects on offspring outcome [12]. Thus far, it is clear that
research has focused on the effects of GDM on the fetus.
Despite the rising prevalence of pre-diabetes, studies on the
impact of gestational pre-diabetes on offspring outcomes
are still scarce [11].
In this study, we will conduct a systematic review of
the existing literature to identify studies that address
both short- and long-term outcomes in the offspring of
pregnant women with pre-diabetes. Our objective is to
determine the risk of developing adverse outcomes for
the offspring in women with pre-diabetes compared to
women with normal glucose levels and women with
GDM. We will compare the three groups and report two
risk comparisons: (1) pre-diabetes vs. normal glucose
levels and (2) pre-diabetes vs. GDM. We hypothesize
that offspring with intrauterine exposure to pre-
diabetes would have a higher risk of developing ad-
verse outcomes compared to those without the expos-
ure. When compared to offspring exposed to GDM,
we hypothesize that those with intrauterine exposure
to pre-diabetes would have a lower risk of adverse
outcomes. Lastly, we aim to identify any gaps in the
literature that exist on this topic.
Methods/design
Criteria for study inclusion
Types of studies
Experimental (randomized and nonrandomized) and ob-
servational studies (prospective/retrospective cohort and
case control) will be considered. Articles must be in
English and address offspring outcomes of mothers with
pre-diabetes during pregnancy. Review articles and arti-
cles without a pre-diabetic study group or without a
control group will be excluded.
Types of participants
We will include studies with pregnant women. There
are three groups of interests: (1) those with pre-
diabetes/abnormal glucose tolerance/impaired fasting
glucose during pregnancy, (2) those with normal glu-
cose levels, and (3) those with diagnosed gestational
diabetes. We will compare the mode of delivery and the
risk of adverse outcomes in offspring across the three
groups. Risk comparisons will be made between group (1)
and group (2), as well as group (1) and group (3).Exposure
During pregnancy, pre-diabetes is diagnosed using a
two-step approach – Glucose Challenge Test (GCT)
followed by an OGTT. Various cutoffs for the GCT
and OGTT are used during diagnosis and are based on
different criteria such as the National Diabetes Data
Group (NDDG), Carpenter and Coustan (C&C), and
World Health Organization (WHO) criteria [13,14].
See Table 1 for plasma glucose values used by the
different diagnostic criteria. Other criteria for pre-
diabetes will also be included if they are clearly
defined. A conversion table for blood glucose monitor-
ing will be used to convert units between mg/dL and
mmol/L [15].
Outcomes
Our primary outcomes of interest will be:
 Birth weight (kg) and offspring weight/body mass
index (BMI) in childhood. The childhood data will
be categorized as neonatal (0 to 28 days), infant
(0 to 1 year), toddlers (1 to 2 years), and preschool
(3 to 5 years). For studies with multiple time points,
data corresponding to the oldest age within each
category will be used.
Our secondary outcomes of interest will be:
 Macrosomia (a birth weight above 4 kg or above the
90th percentile).
 Prematurity (number of offspring born prior to 37
weeks gestation).
 Emergency cesarean sections (number of women
who deliver by C-section).
 Mean Apgar scores at 1 min and at 5 min, and
 Offspring glycemic status (% of offspring with
glucose intolerance).
Outcomes will be reported according to three categor-
ies: pregnancy complications, neonatal outcomes, and
long-term offspring outcomes. Data on pregnancy com-
plications will include prematurity and emergency
cesarean sections. Neonatal outcomes will include mean
birth weight, proportion of children with macrosomia,
and mean Apgar scores at 1 min and at 5 min. In the
event that birth weight is reported in other units such as
grams or pounds, a unit conversion will be conducted.
Long-term offspring outcomes will include offspring
BMI and percent of offspring with glucose intolerance.
Search strategy for identification of studies
We will conduct a search of the published literature
looking for studies reporting outcomes in the offspring
of mothers with pre-diabetes during pregnancy.
Table 1 Plasma glucose values used as diagnostic criteria for gestational diabetes mellitus and pre-diabetes
NDDG (1979)a C&C (1982)a WHO (2006)b
1 hr-GCT (50 g) at 24 to 28 weeks gestation ≥140 (7.8) ≥140 (7.8) 92 to 125 (5.1 to 6.9)
3 hr-OGTT
1 hr ≥190 ≥180 ≥180 (10)
2 hr ≥165 ≥155 153 to 199 (8.5 to 11)
3 hr ≥145 ≥140
Values are expressed in mg/dL (mmol/L). a100 g OGTT; b75 g OGTT. Gestational pre-diabetes is confirmed when there is an abnormal result in the GCT test and
either normal or 1 abnormal OGTT test result [23,24]. If there are two or more abnormal values in the OGTT, the patient is diagnosed with GDM [14]. C&C, Carpenter and
Coustan; GCT, glucose challenge test; NDDG, National Diabetes Data Group; OGTT, oral glucose tolerance test; WHO, World Health Organization.
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We will search the following databases from 1979, which
is the year when the term impaired glucose tolerance
and pre-diabetes were coined [16]: EMBASE, PsycINFO,
and PubMed. The following subject headings (MeSH)
and key terms will be used in various combinations and
adapted for each database: pre-diabetes, prediabetes,
impaired fasting glucose, impaired glucose tolerance,
glucose intolerance, dysglycemia, hyperglycemia, preg-
nancy, maternal, mother, offspring, outcomes, impact,
consequences, metabolic, metabolic syndrome, obesity,
cholesterol, blood pressure, hypertension, atherosclerosis,
cardiovascular. The following section summarizes our
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Reference lists
We will search the reference lists of relevant citations
for articles of interest.
Grey literature
We will contact authors and experts in the field for any
relevant material.
Data collection and analysis
Screening
Two reviewers (RS and LZ) will independently select
studies that meet the following criteria: any article pub-
lished in the English literature addressing outcomes in
offspring of mothers with pre-diabetes during pregnancy.
Citations and abstracts will be screened for relevance,
and duplicate citations will be excluded. Full text
screening will be conducted and article eligibility will
be evaluated using a standardized and pre-tested form.
Disagreements will be resolved by consensus, with
consultation of a third investigator (KM) when reso-
lution cannot be achieved. Corresponding authors will
be contacted in the event that the publication (1) does
not permit us to decide its eligibility, (2) is unclear and
may be subject to multiple interpretations, or (3) has
collected data but did not report data that are relevant
to our study analysis.
Data extraction
Two reviewers (RS and LZ) will independently extract data
in duplicate from included studies, using a standardized
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the study design, setting, sample size, quality score,
how glucose intolerance was measured, confounders,
and details of the outcomes. Specifically, outcomes will
be categorized into mode of delivery, neonatal out-
comes, and long-term offspring outcomes. Rates of
study and comparison groups, along with z-scores,
odds ratios, P values, and confidence intervals, will be
recorded. If offspring weight/BMI data are reported as
z-scores, authors will be contacted in order to obtain
the raw data.
Assessment of methodological quality
Two reviewers (RS and LZ) will independently score the
quality of included studies using the Newcastle-Ottawa
scale (NOS) [17]. The NOS assesses nonrandomized/
observational studies based on eight items categorized
into three groups: (1) the selection of the study groups,
(2) the comparability of the groups, and (3) the ascer-
tainment of either the exposure or outcome of interest
[17]. Discrepancies will be resolved by consensus or by
consulting the third investigator (KM).
Agreement on screening, data abstraction, and meth-
odological quality will be measured using the Kappa
statistic [18].
Analysis and reporting
For outcomes reported as rates or proportions, we will
calculate a pooled estimate of the proportion by weight-
ing the studies by their respective sample sizes. We will
use the random effects model in the meta-analysis of
proportions and investigate sources of heterogeneity
when inconsistency is high (I2 > 75%) [19]. For similar
continuous outcomes with the same measurement scales,
we will report the mean difference (SD). If measurement
scales are different or not readily convertible, we will re-
port the standardized mean difference. Comparisons of
pooled estimates will be made between pre-diabetic/
diabetic groups and the nondiabetic groups of preg-
nant women. We will analyze the data using Review
Manager (RevMan) V.5.3 (The Nordic Cochrane Centre,
The Cochrane Collaboration, 2014, Copenhagen, Denmark)
and Statistical Analysis Software (SAS) V.9.3 (SAS Institute,
2009, Cary, NC, USA) [19]. We will report our findings
according to the preferred reporting items for system-
atic reviews and meta-analyses (PRISMA) and the
meta-analysis of observational studies in epidemiology
(MOOSE) guidelines [20,21]. When statistical data
pooling does not yield meaningful results, such as in
the presence of considerable clinical heterogeneity or
irreconcilable outcome measures, we will conduct a
narrative synthesis. We will construct a funnel plot and
check for asymmetry as well as run a meta-regression
test for publication bias [22].Subgroup analysis
We will perform a primary subgroup analysis based on
maternal BMI, study design (experimental vs. observa-
tional), and methodological quality. Subgroup effect sizes
from the meta-analysis will be reported in comparison
to the overall effect size. Any subgroup differences iden-
tified in the primary subgroup analysis will be described,
and our findings will be interpreted in the light of these
differences. Further exploratory analysis will be conducted
on the following factors if they have been reported at study
level: gestational age, prematurity, maternal age, ethnicity,
socioeconomic status, and level of maternal antenatal care.
Discussion
The effects of gestational diabetes mellitus on offspring
outcomes, both short term and long term, have been
clearly documented, unlike the effects of pre-diabetes. In
this review, we intend to determine the impact of lesser
degrees of glucose intolerance (pre-diabetes) during preg-
nancy on offspring health. We will document the risk of
adverse outcomes in the offspring of women with gesta-
tional pre-diabetes as compared to women with normal
glucose tolerance and those with GDM. Determining the
effect of pre-diabetes on offspring outcome will be import-
ant for clinicians providing care to pregnant women. If
pre-diabetes is found to have adverse effects, this may in-
fluence clinical practice by increasing the number of
women screened and treated for glucose intolerance dur-
ing pregnancy. Furthermore, if long-term consequences
are identified, these offspring may benefit from close
follow-up and attention-to-lifestyle behaviors to prevent
long-term cardiometabolic disorders as is currently rec-
ommended for offspring of mothers with GDM. This re-
view will also identify any gaps in the current literature on
this topic and provide direction for future research in this
area of study.
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